Grant: CIHR Fellowship
Université de Montréal
$105,000.00
Cellular and synaptic mechanisms of TDP-43 proteinopathy using zebrafish.
FY 2011-12
Summary
Amyotrophic Lateral Sclerosis (ALS), or as it is commonly known Lou Gehrig's disease, is a neurodegenerative disorder characterized by the death of a large proportion of motoneurons in the cerebral cortex and spinal cord. The disease onset is in midlife but can occur earlier and progresses from muscle weakness to paralysis and eventual death within 2-5 years. There is one pharmacological treatment for ALS, riluzole, and it is believed to extend the life of individuals with this disease by 2-3 months. Part of the poor success of riluzole can be attributed to our incomplete understanding of the cellular and functional abnormalities resulting from causative mutations in genes such as TARDBP (encoding TDP-43). Mutations in TDP-43 have been found in ALS. Few animal models of TDP-43 mutations have been described and none have characterized the physiological deficits that occur in ALS which result in paralysis. To advance our understanding of this disease I propose to use a zebrafish model previously described by our laboratory in which mutant human TDP-43 or normal TDP-43 is expressed in zebrafish. There are two goals of this research proposal. Firstly, I will investigate the underlying pathophysiology of TDP-43 mutations occurring at the neuromuscular junction (NMJ), which result in poor synaptic transmission. I will use cutting edge electrophysiological and cellular imaging techniques to examine synaptic transmission across the NMJ to ascertain what the dysfunction is and which pharmacological tools will be most useful in restoring synaptic transmission. Secondly, I will investigate the cause of increased excitability of motoneurons in the spinal cord. In particular, I will examine glutamatergic synaptic transmission which is hypothesized to be augmented and be deleterious to motoneurons in ALS patients. This research proposal lays the groundwork needed for a thorough understanding of basic physiological mechanisms of ALS-related motoneuron dysfunction.
Department
Program
CIHR Fellowship
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
252777
Name
Armstrong Gary A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Cellular and synaptic mechanisms of TDP-43 proteinopathy using zebrafish.
Programtype2
Fellowship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cell Biology; Cellular Imaging; Electrophysiology; Neuropharmacology; Patch-Clamp
Abstract
Amyotrophic Lateral Sclerosis (ALS), or as it is commonly known Lou Gehrig's disease, is a neurodegenerative disorder characterized by the death of a large proportion of motoneurons in the cerebral cortex and spinal cord. The disease onset is in midlife but can occur earlier and progresses from muscle weakness to paralysis and eventual death within 2-5 years. There is one pharmacological treatment for ALS, riluzole, and it is believed to extend the life of individuals with this disease by 2-3 months. Part of the poor success of riluzole can be attributed to our incomplete understanding of the cellular and functional abnormalities resulting from causative mutations in genes such as TARDBP (encoding TDP-43). Mutations in TDP-43 have been found in ALS. Few animal models of TDP-43 mutations have been described and none have characterized the physiological deficits that occur in ALS which result in paralysis. To advance our understanding of this disease I propose to use a zebrafish model previously described by our laboratory in which mutant human TDP-43 or normal TDP-43 is expressed in zebrafish. There are two goals of this research proposal. Firstly, I will investigate the underlying pathophysiology of TDP-43 mutations occurring at the neuromuscular junction (NMJ), which result in poor synaptic transmission. I will use cutting edge electrophysiological and cellular imaging techniques to examine synaptic transmission across the NMJ to ascertain what the dysfunction is and which pharmacological tools will be most useful in restoring synaptic transmission. Secondly, I will investigate the cause of increased excitability of motoneurons in the spinal cord. In particular, I will examine glutamatergic synaptic transmission which is hypothesized to be augmented and be deleterious to motoneurons in ALS patients. This research proposal lays the groundwork needed for a thorough understanding of basic physiological mechanisms of ALS-related motoneuron dysfunction.
Competitiondate
201202
Approvedterm2
2 yrs 4 mths
Pinamesdelim
Armstrong, Gary A
Approvedterm
2 ans 4 mois
Cihrcontribution2
~ $105,000~ $0~